Skip to main content

Daliresp Side Effects

Generic name: roflumilast

Medically reviewed by Drugs.com. Last updated on Jul 2, 2023.

Note: This document contains side effect information about roflumilast. Some dosage forms listed on this page may not apply to the brand name Daliresp.

Applies to roflumilast: oral tablet.

Serious side effects of Daliresp

Along with its needed effects, roflumilast (the active ingredient contained in Daliresp) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking roflumilast:

More common

Less common

Other side effects of Daliresp

Some side effects of roflumilast may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

For Healthcare Professionals

Applies to roflumilast: oral tablet.

Psychiatric

Common (1% to 10%): Anxiety, depression

Frequency not reported: Suicidal ideation and behavior (including completed suicide)

Postmarketing reports:[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, nausea, abdominal pain, dyspepsia, gastritis, vomiting[Ref]

Metabolic

Common (1% to 10%): Weight decreased, decreased appetite

Nervous system

Common (1% to 10%): Headache, dizziness, insomnia, tremor[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, muscle spasms[Ref]

Immunologic

Common (1% to 10%): Influenza, rhinitis, sinusitis, urinary tract infection

Genitourinary

Postmarketing reports: Gynecomastia[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity reactions (including angioedema, urticaria, and rash)

References

1. Product Information. Daliresp (roflumilast). Astra-Zeneca Pharmaceuticals. 2011.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.